Experiment: 2KZ2

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	0.8 mM [U-100% 13C; U-100% 15N] cCaMF92E-1	90% H2O/10% D2O	0.1	6.9	ambient	293
2	2D 1H-13C HSQC	0.8 mM [U-100% 13C; U-100% 15N] cCaMF92E-1	90% H2O/10% D2O	0.1	6.9	ambient	293
3	3D CBCA(CO)NH	0.8 mM [U-100% 13C; U-100% 15N] cCaMF92E-1	90% H2O/10% D2O	0.1	6.9	ambient	293
4	3D HNCACB	0.8 mM [U-100% 13C; U-100% 15N] cCaMF92E-1	90% H2O/10% D2O	0.1	6.9	ambient	293
5	3D C(CO)NH	0.8 mM [U-100% 13C; U-100% 15N] cCaMF92E-1	90% H2O/10% D2O	0.1	6.9	ambient	293
6	3D HNCO	0.8 mM [U-100% 13C; U-100% 15N] cCaMF92E-1	90% H2O/10% D2O	0.1	6.9	ambient	293
7	3D H(CCO)NH	0.8 mM [U-100% 13C; U-100% 15N] cCaMF92E-1	90% H2O/10% D2O	0.1	6.9	ambient	293
8	3D HNCA	0.8 mM [U-100% 13C; U-100% 15N] cCaMF92E-1	90% H2O/10% D2O	0.1	6.9	ambient	293
9	3D HN(CA)CO	0.8 mM [U-100% 13C; U-100% 15N] cCaMF92E-1	90% H2O/10% D2O	0.1	6.9	ambient	293
10	3D HCCH-TOCSY	0.8 mM [U-100% 13C; U-100% 15N] cCaMF92E-1	90% H2O/10% D2O	0.1	6.9	ambient	293
11	3D CCH-TOCSY	0.8 mM [U-100% 13C; U-100% 15N] cCaMF92E-1	90% H2O/10% D2O	0.1	6.9	ambient	293
12	3D N15-NOESY	0.8 mM [U-100% 13C; U-100% 15N] cCaMF92E-1	90% H2O/10% D2O	0.1	6.9	ambient	293
13	3D C13-NOESY	0.8 mM [U-100% 13C; U-100% 15N] cCaMF92E-1	90% H2O/10% D2O	0.1	6.9	ambient	293
14	3D N15/C13-NOESY	0.8 mM [U-100% 13C; U-100% 15N] cCaMF92E-1	90% H2O/10% D2O	0.1	6.9	ambient	293
15	2D 1H-15N HSQC IPAP	0.4 mM [U-100% 13C; U-100% 15N] cCaMF92E-2	90% H2O/10% D2O	0.1	6.9	ambient	293

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	DMX	600
2	Varian	INOVA	600

NMR Refinement
Method	Details	Software
simulated annealing		AutoStructure

NMR Ensemble Information
Conformer Selection Criteria	structures with the lowest energy
Conformers Calculated Total Number	100
Conformers Submitted Total Number	20
Representative Model	1 (lowest energy)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	refinement	AutoStructure		Huang, Tejero, Powers and Montelione
2	structure solution	CYANA		Guntert, Mumenthaler and Wuthrich
3	processing	NMRPipe		Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
4	data analysis	SPARKY		Goddard
5	structure solution	TALOS		Cornilescu, Delaglio and Bax
6	data analysis	XEASY		Bartels et al.
7	refinement	X-PLOR_NIH		Schwieters, Kuszewski, Tjandra and Clore

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.